|
CN111253475A
|
|
GLP-1 agonist polypeptide compound and salt thereof, and synthesis method and application thereof
|
|
CN110684082A
|
|
GIP and GLP-1 dual-agonist polypeptide compound, pharmaceutically acceptable salt and application
|
|
CN110128526A
|
|
Long-actingization Exenatide derivative and its salt and preparation method and purposes
|
|
CN109705206A
|
|
A kind of purification process and purposes of thymalfasin
|
|
CN109456403A
|
|
A kind of synthetic method of Liraglutide
|
|
CN109456404A
|
|
A kind of synthetic method for degree Shandong peptide
|
|
CN109456402A
|
|
A kind of synthetic method of Suo Malu peptide
|
|
CN109438560A
|
|
A kind of liquid-phase synthesis process of Buserelin
|
|
CN109593118A
|
|
A kind of liquid-phase synthesis process of Leuprorelin
|
|
CN108165594A
|
|
A kind of synthetic method of Pidotimod
|
|
CN107936094A
|
|
The synthetic method that a kind of solid liquid phase of Li Laluo peptides is combined
|
|
CN108034004A
|
|
A kind of synthetic method of Suo Malu peptides
|
|
CN107903318A
|
|
A kind of method for purifying Liraglutide
|
|
CN107903317A
|
|
A kind of synthetic method of Liraglutide
|
|
CN107892717A
|
|
A kind of method of purifying Suo Malu peptides
|
|
CN106589072A
|
|
Synthesis method of goserelin
|
|
CN106589071A
|
|
Synthetic method of degarelix
|
|
CN106397580A
|
|
Bivalirudin synthesis method
|
|
CN106188218A
|
|
A kind of method improving polypeptide raw material drug stabilisation
|
|
CN105330726A
|
|
Leuprorelin synthesis method
|
